Jeong Seok Cha

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Nlrp Inflammasome

Top Venues

Cell death discovery

Molecules and cells

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tae-Geun Yu, Jeong Seok Cha, Gijeong Kim, Yoo-Kyoung Sohn, Youngki Yoo, Uijin Kim, Ji-Joon Song, Hyun-Soo Cho, Hak-Sung Kim
Correction: Oligomeric states of ASC specks regulate inflammatory responses by inflammasome in the extracellular space. Cell death discovery 9 (1) (2023)
Tae-Geun Yu, Jeong Seok Cha, Gijeong Kim, Yoo-Kyoung Sohn, Youngki Yoo, Uijin Kim, Ji-Joon Song, Hyun-Soo Cho, Hak-Sung Kim
Oligomeric states of ASC specks regulate inflammatory responses by inflammasome in the extracellular space. Cell death discovery 9 (1) (2023)
Tae-Geun Yu, Jeong Seok Cha, Gijeong Kim, Yoo-Kyoung Sohn, Youngki Yoo, Uijin Kim, Ji-Joon Song, Hyun-Soo Cho, Hak-Sung Kim
Oligomeric states of ASC specks regulate inflammatory responses by inflammasome in the extracellular space. Cell death discovery 9 (1) (2023)
Danbi Yoon, Ju Heun Moon, Anna Cho, Hyejoon Boo, Jeong Seok Cha, Yoonji Lee, Jiho Yoo
Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin. Molecules and cells (2023)
Mirim Hong, Youngki Yoo, Miyoung Kim, Ju Yeon Kim, Jeong Seok Cha, Myung Kyung Choi, Uijin Kim, Kyungyong Kim, Youngsoo Sohn, Donggoo Bae, Hyun-Soo Cho, Seung-Beom Hong
A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization. Molecular cancer therapeutics 20 (6) (2021)
Sung-Hoon Jun, Jae-Kyung Hyun, Jeong Seok Cha, Hoyoung Kim, Michael S Bartlett, Hyun-Soo Cho, Katsuhiko S Murakami
Direct binding of TFEα opens DNA binding cleft of RNA polymerase. Nature communications 11 (1) (2020)